GISELA REGALADO PAREDES
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LANCASTER, CA NPI 1629698253
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA Novo Nordisk AS All categories
General Payments — all program years on this page
$2,696.53
- Category: General Payments
- Program years: PY2021–2024
- Record count: 123
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $175.31 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $175.31 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $63.75 | 3 |
| GlaxoSmithKline, LLC. | $37.73 | 2 |
| DEXCOM, INC. | $31.79 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $21.08 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.96 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1100425565 | Novo Nordisk Inc | $20.84 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100440817 | Novo Nordisk Inc | $21.92 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100518601 | Novo Nordisk Inc | $20.99 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116634646 | GlaxoSmithKline, LLC. | $23.36 | 10/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116707991 | GlaxoSmithKline, LLC. | $14.37 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118087822 | Boehringer Ingelheim Pharmaceuticals, Inc. | $20.96 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147022652 | AIMMUNE THERAPEUTICS, INC. | $21.08 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153361728 | Dexcom, Inc. | $31.79 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.